[KROS] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
04-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -29.93%
YoY- -68.64%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 100 0 20,000 0 100 0 0 -
PBT -27,266 -24,186 -4,942 -20,335 -15,622 -15,835 -10,676 87.16%
Tax -3,462 1 1,998 -38 -79 50 82 -
NP -23,804 -24,187 -6,940 -20,297 -15,622 -15,885 -10,676 70.92%
Tax Rate - - - - - - - -
Total Cost 23,904 24,187 26,940 20,297 15,722 15,885 10,676 71.40%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -23,804.00 0.00 -34.70 0.00 -15,622.00 0.00 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.99 -1.01 -0.30 -0.87 -0.67 -0.68 -0.49 60.02%
EPS Diluted -0.99 -1.01 -0.30 -0.87 -0.67 -0.68 -0.49 60.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.